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Background: To confirm the efficacy of preoperative workup, the authors analyse the results of a multicentre study
in a surgical series of patients diagnosed with an adrenal incidentaloma.
Methods: The retrospective review of a prospectively collected database was conducted. The data was obtained by
six surgical units operating in the Campania Region, Italy. Five-hundred and six (506) adrenalectomies performed
between 1993 and 2011 on 498 patients were analysed. Final histology in patients with a preoperative diagnosis of
incidentaloma and studied according to guidelines (230/282 patients group A) was compared with final histology
coming from patients presenting the same preoperative diagnosis but studied not according to guidelines
(52/282 patients group B).
Results: In group A preoperative diagnosis was confirmed at final histology in 76/81 (93.8%) cases of subclinical
functioning lesions presenting as an incidentaloma. The preoperative detection of pheochromocytoma and primary
adrenocortical cancer (ACC) reached 91.6% and 84.6% respectively. In group B conversion rate to open surgery was
higher than in group A (p = 0.02). One pheochromocytoma was missed at preoperative diagnosis whereas one ACC
smaller than 4 centimetres (cm) and coming from an incidental lesion was discovered. In both groups a significant
association between increasing dimensions of incidentaloma and cancer has been observed (p = 0.001).
Conclusions: This surgical series confirm the high efficacy of suggested guidelines. A significant preoperative
detection rate of adrenal lesions presenting as incidentaloma is observed. The unnecessary number of
adrenalectomies performed in understudied patients, causing higher morbidity, was not associated to a higher
detection rate of primary adrenocortical cancer.
Keywords: Laparoscopic adrenalectomy, Incidentaloma, Adrenocortical cancer, Preoperative workup,
Pheochromocytoma, GuidelinesBackground
The term “incidentaloma” is widely used to define the age
increasing prevalence of incidentally discovered adrenal
masses in 3 to 10% of patients undergoing imaging modal-
ities, mainly CT-scan and magnetic resonance imaging
(MRI), for other clinical indications [1,2]. These neoplasms
represent the most frequent adrenal tumours encountered
by physicians and they are accompanied with a negative* Correspondence: mario.musella@unina.it
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reproduction in any medium, provided the orclinical functional status, thus they are often defined as
“challenging” in terms of preoperative diagnosis and man-
agement [1]. This is due to both their imaging characteris-
tics, that sometimes do not permit the radiologists to
formulate a diagnosis, and because fine needle aspiration
biopsy (FNAB) does not always allow to distinguish benign
from malignant primary adrenocortical tumours [3].
Despite these challenges, the goal of the clinicians dealing
with an adrenal incidentaloma remains to remove function-
ing and malignant lesions without performing an useless
adrenalectomy in non-functioning small benign tumours.l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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concerning the correct management of adrenal incidenta-
lomas have been proposed by the United States National
Institute of Health (NIH) and by the American Association
of Clinical Endocrinologists/American Association of
Endocrine Surgeons (AACE/AAES) [4,5]. When an adrenal
incidentaloma is detected, according to these statements,
the main clinical aims are to rule out the occurrence of
any subclinical cortisol or aldosterone secreting lesion,
to exclude a pheochromocytoma, and, finally, to resect all
adrenal non-functioning lesions suspicious for adrenocor-
tical cancer (ACC) at imaging.
If a secreting lesion is detected, the indications to treat-
ment vary from a more aggressive attitude for pheochro-
mocytoma to a non surgical management to be preferred
in some cases of cortisol or aldosterone subclinical secret-
ing lesions [5]. Additionally, two more points are clearly
established. Firstly, adrenal masses identified as potential
metastases during the staging of an extra adrenal cancer
should be not considered as incidentalomas; secondly, most
non secreting lesions larger than 4 cm must be removed
due to the increased risk of an ACC irrespectively of their
imaging status [5].
In this last decade laparoscopic adrenalectomy has
gained gold standard status. It is widely used to resect
almost all adrenal lesions, limiting open surgery to spe-
cific indication [6]. Although several experts have tried
to define the ideal management of incidentalomas
reaching the conclusion that, regardless of the surgical
approach, open or laparoscopic, the indications to sur-
gery through the years have not changed [7-10], some
articles have demonstrated that the introduction of
laparoscopy has caused an increase in the number of
adrenalectomies performed on patients with incidenta-
lomas [11-13]. In our study the final histology of 282
consecutive laparoscopic adrenalectomies performed
at different institutions for incidentaloma, was evalu-
ated. Patients have been then divided in two groups.
Group A included patients who received a preoperative
workup according to protocols [4,5], while patients whose
pre-surgical workup did not follow current guidelines
were included in group B.
The aims of this study were:
1. To define in both groups in which rate preoperative
work-up has matched final diagnosis when an
incidentaloma was detected, especially for suspected
pheochromocytoma and primary ACC.
2. To determine if unnecessary adrenalectomies in
group B led to a higher rate of discovery of
incidental cancer, thus suggesting a possible shift in
surgical indications.
3. To compare if morbidity in patients who received
a preoperative workup according to protocols(Group A) was significantly different from that of
understudied patients (Group B).
Methods
Study setting and timing
To investigate the three points defined in the introduc-
tion, a questionnaire was prepared by four authors
(MM, BB, RP, AC) working at the “Federico II” University
and e-mailed at the end of 2011 to surgical units with an
experience of more than fifty laparoscopic adrenalectomy
operating in the Campania Region, Italy. Seven surgeons
from six centres participated in this audit: 2 university
centres (1 from Naples Second University “SUN” and 1
from Naples “Federico II” University), and 3 regional
hospitals with four centres. The duration of data ana-
lysis ranged from January 1993 to December 2011.
During this period 506 laparoscopic adrenalectomies
(LA) were performed on 498 patients. Male patients
were 177 (35.5%). Mean age was 49.7 (range 16–78). In
282 cases, (55.7%) the resection was performed due to
a preoperative diagnosis of adrenal incidentaloma. All
six centres began, starting from 2001, a strict collabor-
ation with the endocrinology unit of the “Federico II”
University in terms of biochemical assessment, im-
aging evaluation and indication to surgery of detected
incidental lesions.
Study design
The retrospective review of a prospectively collected
database was conducted. The main parameters asked in
the questionnaire defined:
1. The preoperative functional status and the dimensions
of the lesions obtained by biochemical study, CT
scan with or without contrast, MRI, radionuclide
scanning (MIBG, FDG PET, PET-CT or NP-59) or
eventually FNAB.
2. Indications to surgery
3. The surgical records in terms of operative time,
number of ports used and intraoperative
complications, eventually requiring conversion to
open surgery.
4. The postoperative records in terms of duration of
hospital stay, complications eventually requiring
re-intervention, final dimension and histology of the
specimen, and survival data for malignant lesions.
All data recorded later than 1999 were saved on elec-
tronic sheets under the supervision of the surgical units
heads. Part of the data was collected manually before
that period. All records, once returned, were then intro-
duced in a database under the supervision of the authors of
the questionnaire for computer processing. A data quality
control was performed at that time.
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and divided in two groups.
When preoperative diagnosis was “incidentaloma”
(282/506 adrenalectomies), only 230/282 lesions (81.5%)
underwent, at the time of diagnosis, both a biochemical
and radiological investigation, performed by the same
endocrinologists group, acting as coordinator. The study,
according to guidelines [5], was aimed to:
Rule out subclinical cortisol secreting lesion by an
overnight 1 mg dexamethasone suppression test. A re-
sponse providing values lower than 5 μg/dL was con-
sidered normal.
Rule out any subclinical aldosterone secreting lesion by
evaluating serum potassium and the plasma aldosterone
concentration/plasma renin activity ratio. The cut-off was
considered a plasma aldosterone concentration-plasma
renin activity ratio greater than 30 and a plasma aldoster-
one concentration greater than 0.5 nmol/L (20 ng/dL).
Evaluate 24-hour total urinary metanephrines and frac-
tionated catecholamines (or both plasma and urine study)
to exclude a pheochromocytoma. A 24-hour urine total
metanephrine level above 1,800 μg and a plasma meta-
nephrine level exceeding 3 times normal were assumed
diagnostic for a pheochromocytoma.
Conversely, once defined lesions smaller than 4 cm, with
benign non contrast CT scan features, all non-functioning
lesions looking indeterminate or malignant, were evaluated
by using a contrast enhanced CT scan or alternatively in
38/230 cases by MRI. In 25/230 cases a PET-CT scan was
however used due to the inconclusive response of CT scan
[14]. An imaging pattern not fulfilling the CT scan criteria
although suggestive of malignancy was defined indeter-
minate. The criteria used, indicating a primary ACC in
non-functioning incidentalomas were [9,15,16]:
 An attenuation value higher than 10 HU on non
contrast CT scan
 A contrast agent washout lesser than 50%
 Dimension bigger than 6 cm.
 Irregular shape, central necrotic areas, vena cava
thrombosis.
Indication to surgery in this group of incidentally
discovered lesions were then considered:
 Non functioning lesions larger than 4 cm (76 patients)
 Non functioning lesions smaller than 4 cm but
increasing in radiographic dimensions or becoming
hormonally active within the first year from
diagnosis (75 patients)
 Monolateral aldosterone producing masses (18 patients)
 Hormonally active pheochromocytomas (22 patients)
 Patients younger than 40 presenting with a subclinical
Cushing syndrome [17] of recent onset andaccompanied by worsening of hypertension, abnormal
glucose tolerance and osteoporosis (39 patients)
These patients studied and treated according to guide-
lines, were classified and included in group A.
The remaining 52/282 (18.5%) lesions were preoperatively
studied elsewhere with incomplete imaging and underwent
surgical resection without further biochemical testing. Most
of them (49/52, 94.2%) were treated from 1993 to 2000,
at the beginning of the laparoscopic adrenalectomy experi-
ence. Incomplete imaging means CT scan performed with-
out contrast when requested or without measuring contrast
washout kinetics [4,5]. In these patients, classified as group
B, MRI or nuclear scanning were never used. The lack of
any clinical manifestation of endocrine activity in presence
of an incidental adrenal lesion, evaluated as resectable
at imaging, was considered a valid indication to surgery.
They, according to the authors of the questionnaire, did
not fulfill the preoperative study criteria requested to be
included in group A.
All incidental lesions presenting an elevation of 24-hours
urinary metanephrines and fractionated catecholamines
in group A were treated with an α adrenergic blockade
before resection. Subtotal adrenalectomies were not
performed. Six patients (1.2%) were approached in supine
transabdominal position. The posterior retroperitoneal ap-
proach was not used. The “Federico II” University ethical
committee, which is the reference centre for our region,
authorized the use of all data concerning this study. Before
surgery, all patients signed an informed consent, requested
by Italian laws and granted by our ethical committee,
explaining in detail all the risks and the benefits provided
by adrenalectomy.
Statistical analysis was performed with SPSS version
14.0 (SPSS©, Chicago, IL, USA). The Yates corrected χ2 test
was used as a means of evaluating differences in category
variables, and the independent sample test was used
for continuous variables. Significance was assigned at a
level of p <0.05.
Results
No deaths occurred in this audit. The general morbidity
was 7.8% (22/282), see Table 1. The mean hospital stay
was 4.1 days in group A patients vs. 4.6 days in group
B (p = ns). Conversion rate to open surgery was signifi-
cantly higher in group B (6/52 11.5%) than in group A
(8/230 3.47%) (p = 0.02). Table 2 refers to group A
(230/282 81.5%) whereas Table 3 reports final histology
for group B (52/282 18.5%) incidental lesions. Among
the lesions studied according to guidelines [4,5], final
histology matched the preoperative diagnosis for all
(100%) subclinical cortisol and aldosterone secreting
lesions. Remaining in the field of incidental function-
ing lesions it must be noted that:
Table 1 Morbidity rate in 282 laparoscopic adrenalectomies for incidentaloma with final histology
Complication Group A Group B
Intraoperative bleeding 3 ACC > 6 cm *; 1 myelolipoma > 6 cm* 3 nonfunctioning adenomas < 4 cm*; 1 ACC > 4 cm*
Cava vein tear 1 ACC > 6 cm*
Liver injury 2 ACC > 6 cm* 1 non functioning adenoma < 4 cm*
Spleen injury 1 myelolipoma > 6 cm* 1 non functioning adenoma < 4 cm*
Postoperative bleeding 2 ACC > 6 cm** 2 nonfunctioning adenomas < 4 cm**
Port site hematoma 1 nonfunctioning adenoma > 6 cm 1 myelolipoma
Port site infection 1 myelolipoma > 6 cm
Postoperative uncontrolled blood pressure 1 pheochromocytoma
Total 12/230 (5.2%) 10/52 (19.2%)
*Conversion to open surgery required.
**In one case surgical revision required.
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group A and 1/52 (1.9%) untested lesions in group
B were pheochromocytomas at final histology
(the patient with postoperative uncontrolled
change in blood pressure).
 19/24 pheochromocytomas (79.1%) in group A
presented an elevation of 24-hours urinary
metanephrines and fractionated catecholamines
higher than twice the upper limit. This was a
significant association (p = 0.001).
 3/24 pheochromocytomas (12.5%) in group A
presented an elevation of 24-hours urinary
metanephrines and fractionated catecholamines which
was lower than twice the upper limit. A significant
association was also observed (p = 0.001).
 2/24 pheochromocytomas (8.3%) in group A
presented with normal 24-hours urinary
metanephrines and fractionated catecholamines levels.
 1/4 (25%) ganglioneuromas at final histology
presented an elevation of 24-hours urinary
metanephrines and fractionated catecholamines
levels. It was lower than twice the upper limit.ble 2 Postoperative diagnosis for 282 laparoscopic adrenal
imensions
lesions < 4 cm
n functioning adenoma 63(56.2)
rtisol secreting adenoma 20(17.8)
dosterone secreting adenoma 8(7.1)
eochromocytoma 11(9.8)
renocortical cancer ———————
yelolipoma 8(7.1)
nglioneuroma 2(1.7)
matoma ———————
st ———————
tal 112(48.6)
oup A, 230/282 patients studied according to guidelines.
mensions, n. (%) of adrenalectomies.However, by considering non-functioning lesions
preoperatively classified as incidentaloma it was ob-
served how:
 8/13 ACC (61.5%) had a malignant imaging pattern
showing both an attenuation value higher than 10
Hounsfield units (HU) at noncontrast CT-scan and
a late washout at contrast CT-scan. All lesions were
larger than 6 cm.
 3/13 ACC (23%) had an indeterminate diagnosis at
imaging. One was a 5.2 cm lesion at CT scan whereas
the remaining two were lesions larger than 6 cm.
 2/13 ACC (15.3%) showed a benign pattern at
imaging. One was a 2 cm lesions at CT scan
whereas the second one size was 4.5 cm. Both came
from the 52/282 understudied lesions (Group B)
described in Table 3.
Globally we found 1 stage I (T1, N0, M0), 9 stage II
(T2, N0, M0) and 1 stage III (T3, N0, M0) cancers in
group A. Conversely, 2 stage I cancers were found in
group B.ectomies performed for incidentaloma with specimen
lesions 4–6 cm lesions > 6 cm
28(35.8) 10(25)
15(19.2) 4(10)
7(8.9) 3(7.5)
10(12.8) 3(7.5)
1(1.2) 10 (25)
13(16.6) 5(12.5)
1(1.2) 1(2.5)
——————— 1(2.5)
3(3.8) 3(7.5)
78(33.9) 40(17.3)
Table 3 Postoperative diagnosis for 282 laparoscopic
adrenalectomies performed for incidentaloma with
specimen dimensions
lesions
< 4 cm
lesions
4–6 cm
lesions
> 6 cm
Non functioning adenoma 25(48) 4(7.6) 14(26.9)
Cortisol secreting adenoma - - -
Aldosterone secreting adenoma - - -
Pheochromocytoma 1(1.9) - -
Adrenocortical cancer 1(1.9) 1(1.9) -
Myelolipoma 2(3.8) - 1(1.9)
Ganglioneuroma - - -
Hematoma - 2(3.8) -
Cyst 1(1.9) - -
Total 30(57.6) 7(13.4) 15(28.8)
Group B, 52/282 patients not studied according to guidelines.
Dimensions, n. (%) of adrenalectomies.
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lesions (group A + B) with suspicious imaging features
(ACC vs. non-functioning benign adenomas) we observe
that 1/89 (1.12%) lesion lesser than 4 cm, 2/34 (5.8%)
lesions between 4 and 6 cm and 10/36 lesions larger
than 6 cm (27.7%) were primary ACC. In general in-
creasing dimensions were significantly associated with
ACC (p = 0.001). However, if we compare lesions bigger
than 6 cm with lesions between 4 and 6 cm and with
lesions smaller than 4 cm, a significant correlation with
cancer is shown (p = 0.03 and p = 0.01 respectively),
whereas by comparing lesions between 4 and 6 cm with
lesions smaller than 4 cm a significant probability of finding
a cancer was not observed (p = 0.08).
Discussion
This retrospective study, involving six independent sur-
gical units, covers a period of nineteen years. For this
reason it is important to highlight limits such as the lack
of a central laboratory assessment for some patients, the
differences in imaging quality due to technical evolution,
the distinct scanning equipment that different centres
have used and finally the historical absence of guidelines
to treat adrenal incidentalomas before 2002. Furthermore
it is strictly a surgical series, in which, if final histology is
in any case provided, on the other hand no information
is given about incidental lesions that were not resected.
Nevertheless, evaluating the points raised in the intro-
duction and observing the results, in our opinion some
conclusions might be suggested. By considering 230/282
group A incidentalomas, we found 3/24 (12.5%) pheochro-
mocytomas to have a borderline elevation of metanephrine
levels and 2/24 lesions (8.3%) showing normal metanephr-
ine levels, being a pheochromocytoma at final histology.
Nevertheless it has to be remarked how in these group oflesions, studied according to protocols [4,5], a preopera-
tive diagnosis for 39/39 cortisol secreting lesions, 18/18
aldosterone secreting lesions and 19/24 (79.1%) pheo-
chromocytomas was obtained. Thus, if we consider only
subclinical functioning lesions at final histology presenting
as an incidentaloma, a correct preoperative diagnosis was
reached in 76/81 (93.8%) lesions. This appears especially
important for pheochromocytomas. These lesions must
not only be resected [1-5] but diagnosed and treated by an
α adrenergic blockade before surgery, to avoid intraopera-
tive hemodynamic instability [18,19].
However, if we consider non-functioning incidental
lesions, the preoperative detection rate decreases. In
fact, although sometimes suggested, a specific imaging,
CT scan or MRI, pattern for adrenal incidentalomas,
allowing a preoperative diagnosis, has been never defined
[10,20]. Only 8/13 (61.5%) ACC were actually preopera-
tively addressed by imaging in this series. It may therefore
be concluded that, despite the accuracy of preoperative
evaluation, about 20.9% of incidental pheochromocytomas
and 38.5% of primary cancers miss a preoperative diagnosis.
An acceptable 22/24 (91.6%) and 11/13 (84.6%) pre-
operative detection for pheochromocytoma and primary
ACC respectively would however be achieved for both
functioning and non-functioning lesions if a further 3/24
borderline pheochromocytomas and 3/13 indeterminate
cancers at imaging were considered. These results would
also be in line with recent papers [19,21,22] in which
both the efficacy of preoperative biochemical testing,
or CT and MRI imaging, led preoperative diagnosis to
match final histology in a rate ranging from 80 to 90%
of resected incidental lesions.
An 18.5% rate (52/282 group B) of lesions classified as
“incidental” and described in Table 3 has been on the
other hand resected without an accurate preoperative
study. This occurred in 49/52 patients (94.2%) treated
from 1993 to 2000, when most of the centers participating
in our audit were starting their laparoscopic adrenalectomy
experience. This disputable attitude has however some
plausible explications. The first one, as well as the lack
of common endocrine coordination for the participating
surgery units, was surely represented by the absence of
defined guidelines to treat adrenal incidentalomas be-
fore 2002 [4,5]. The second reason was the trend to use
small incidental lesions to improve the laparoscopic
adrenalectomy learning curve. This attitude, justified by the
unpredictable risk of cancer in any non functioning lesion,
has been however emphasized in other papers [11-13] to
explain the increased number of adrenalectomies that
conversely, would have been never performed before the
laparoscopic age. A concept supported by the observation
that if CT scan tends to underestimate the real dimension
of adrenal lesions [23], on the other hand the improve-
ment in imaging quality [11] has allowed the identification
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this aggressive surgical attitude has led to the detection of
one 1/30 (3.3%) adrenocortical cancer among all lesions
smaller than 4 cm, it must be highlighted the occurrence
of unnecessary resection in 25/52 (48.5%) non-functioning
adenomas smaller than 4 cm (Table 3); this value is signifi-
cantly higher than the 63/230 (27.3%) lesion rate observed
in group A (p = 0.005). This result, together with an higher
intraoperative complication rate, led to a number of con-
version to open surgery significantly higher in group B
than in group A. In this perspective, both the overall mor-
bidity rate of 10.9% and the mortality rate of 0.3% de-
scribed for laparoscopic adrenalectomy [24], have to be
reminded. Moreover the preoperative diagnosis of 1/52
(1.9%) subclinical pheochromocytoma has been missed.
While the respect of current guidelines is undisputed
about the indication to resect incidental non-functioning
lesions larger than 4 cm, the observation that an incorrect
protocol on 52/282 patients has led to discover a small inci-
dental cancer in 1/30 lesion lesser than 4 cm (3.3%) should
cause some concern. Although our data exceeds previous
papers reporting to 2% the detection rate of primary cancer
coming from incidental non-functioning lesions smaller
than 4 cm. [7-9,25,26], one instance of incidental cancer
in a 2 cm lesion is probably not enough to suggest a
shift in surgical indication, especially if we consider the
entire series of 282 incidentalomas. In that case the cancer
rate in incidentalomas smaller than 4 cm would be 1/142
(0.7%), in close agreement with the previously published
range. Additionally, according to recent papers, resecting
incidental adrenal lesions smaller than 4 cm appears to
be not only unnecessary but also cost-ineffective [27].
However in this direction, although a wait and see policy
is accepted, a clear consensus about the follow-up of these
small lesions is still missing [4,5,21], sometimes reaching
critical positions [28].Conclusions
We might therefore conclude, returning to the points
raised in the introduction, that a high preoperative de-
tection rate of lesions presenting as an adrenal inciden-
taloma has been achieved in patients studied according
to guidelines. Conversely, the unnecessary number of
adrenalectomies performed in understudied patients,
causing higher intra- and peri-operative morbidity, has
not determined any significant change in the rate of pri-
mary adrenocortical cancer detected.
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